SP

Sagar Pramod Doshi

Active Director Director DIN 06851208
DIN 06851208 First appointment Jul 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2014
Shareholding value •••• Premium profile

About Sagar Pramod Doshi

Data last updated:

Sagar Pramod Doshi is a Director at Medtabs Pharma Private Limited (since 2014). The company operates in Healthcare. Medtabs Pharma Private Limited reported revenue of ₹2.71 Cr (FY 2024).

DIN 06851208
Primary Designation Director
Industry Healthcare
First Appointment 03 Jul 2014
Oldest Company Age 12 yrs
Largest company Medtabs Pharma Private Limited · ₹2.71 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medtabs Pharma Private Limited U85100PN2014PTC151685
Director03 Jul 20142014₹2.71 Cr (FY 2024)Active

Board colleagues of Sagar Pramod Doshi

Directorship timeline

Open interactive timeline →
Medtabs Pharma Private Limited
Premium access

Shareholding and investment profile for Sagar Pramod Doshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sagar Pramod Doshi

Sagar Pramod Doshi currently holds 1 directorship: Medtabs Pharma Private Limited (Director, since 03 Jul 2014, revenue ₹2.71 Cr (FY 2024)).

Sagar Pramod Doshi was first appointed on 03 Jul 2014 as Director at Medtabs Pharma Private Limited.

The current boards of Sagar Pramod Doshi's companies include Angha Sanjay Apte (Medtabs Pharma Private Limited), Prashant Ganpati Wankar (Medtabs Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available